Stock Code
603707.SH
ABOUT
>
Company profile
Enterprise Culture
Early Warning System
BUSINESS
>
Commercialized Products
MEDIA
>
News in NKF
CONTACT
CH / EN
Media Center
Home
>
MEDIA
>
News in NKF
All year
2025
2024
2023
News in NKF
NKF makes its debut at CPHI Southeast Asia
It has opened up new channels for the company to penetrate the Southeast Asian and even the global market
2025-07-21
Learn more +
King-Friend will meet you in CPHI Malaysia！
Explore the infinite possibilities of the pharmaceutical industry!
2025-07-14
Learn more +
NKF's subsidiary Kindos's Idarubicin Hydrochloride Injection gets FDA approval for marketing
Continue to promote high-quality products and services to a new level
2025-05-26
Learn more +
NKF's subsidiary Kindos's Mitoxantrone Injection gets FDA approval for marketing
Another quick approval
2025-05-22
Learn more +
Paclitaxel For Injection (Albumin Bound) approved by US FDA
2025-05-20
Learn more +
King-Friend will meet you in CPHI Frankfurt!
Explore the infinite possibilities of the pharmaceutical industry！
2025-05-19
Learn more +
King-Friend will meet you in CPHI Shanghai!
Explore the infinite possibilities of the pharmaceutical industry！
2025-05-13
Learn more +
NKF's Liraglutide Injection gets FDA approval for marketing
Benefiting more patients around the world.
2025-04-04
Learn more +
NKF's Rocuronium Bromide Injection getting approved by NMPA
Bring new hope for health to thousands of patients.
2025-03-01
Learn more +
1
2
3
